Evidence map›Paper›PMID 27471233›Full record

ArticleBlood2016

Impaired von Willebrand factor adhesion and platelet response in thrombospondin-2 knockout mice.

Nina Kristofik, Nicole E Calabro, Weiming Tian, Aaron Meng, Susan MacLauchlan, Yinong Wang, Christopher K Breuer, George Tellides, Laura E Niklason, Themis R Kyriakides

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 36 citations in OpenAlex.

  1. The Role of Thrombospondin-2 in Myocardial Fibrosis.Drug design, development and therapy · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. HIF-1α represses the expression of the angiogenesis inhibitor thrombospondin-2.Matrix biology : journal of the International Society for Matrix Biology · 2018
    Article
  11. Article
  12. Molecular targeting in acute myeloid leukemia.Journal of translational medicine · 2017
    Review
  13. Review
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Nina KristofikDepartment of Biomedical Engineering, School of Engineering and Applied Science.
Nicole E CalabroDepartment of Pathology, and.
Weiming TianDepartment of Pathology, and.
Aaron MengDepartment of Biomedical Engineering, School of Engineering and Applied Science.
Susan MacLauchlanDepartment of Pathology, and.
Yinong WangDepartment of Pathology, and Department of Surgery, School of Medicine, Yale University, New Haven, CT;
Christopher K BreuerDepartment of Surgery, Nationwide Children's Hospital, Columbus, OH; and.
George TellidesDepartment of Surgery, School of Medicine, Yale University, New Haven, CT;
Laura E NiklasonDepartment of Biomedical Engineering, School of Engineering and Applied Science, Department of Anesthesiology, School of Medicine, Yale University, New Haven, CT.
Themis R KyriakidesDepartment of Biomedical Engineering, School of Engineering and Applied Science, Department of Pathology, and.
Applied Science Private University · JOYale University · USNationwide Children's Hospital · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Surgery / Physiology CoreP01HL107205 · NHLBI · YALE UNIVERSITY · PI SIMONS, MICHAEL · 2012 to 2022
$18.8M
INSTITUTIONAL NATIONAL RESEARCH SERVICE AWARDT32GM007324 · NIGMS · YALE UNIVERSITY · PI BENNETT, ANTON M · 1987 to 2022
$6.2M
Biological Vascular GraftsR01HL083895 · NHLBI · YALE UNIVERSITY · PI NIKLASON, LAURA E · 2006 to 2015
$5.7M
MCP-1 and attenuation of the foreign body responseR01GM072194 · NIGMS · YALE UNIVERSITY · PI KYRIAKIDES, THEMIS R · 2005 to 2018
$4.7M
Mechanisms of Vascular Neotissue Formation In Tissue Engineered Vascular GraftsR01HL098228 · NHLBI · YALE UNIVERSITY · PI BREUER, CHRISTOPHER KANE · 2010 to 2018
$3.6M
Hyaluronan Coatings for Engineered VesselsR01HL127386 · NHLBI · YALE UNIVERSITY · PI NIKLASON, LAURA E · 2016 to 2019
$2.5M
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS P01 HL107205NHLBI NIH HHS R01 HL083895NHLBI NIH HHS R01 HL098228NHLBI NIH HHS R01 HL127386NIGMS NIH HHS R01 GM072194NIGMS NIH HHS T32 GM007324
6 · The paper itself

Abstract

Interactions between collagenous extracellular matrices and von Willebrand factor (VWF) are critical for hemostasis and thrombosis. In the present study, we investigated the contribution of an extracellular matrix (ECM) abnormality to the bleeding diathesis in thrombospondin-2 (TSP2) knockout (KO) mice. First, we performed adoptive bone marrow transplantation and observed that introduction of wild-type (WT) marrow into lethally irradiated TSP2 KO mice did not rescue the bleeding diathesis. However, platelets in transplanted mice displayed an inherent aggregation defect, which complicated interpretation. Second, we performed interposition of arterial segments denuded of endothelium. Denuded TSP2 KO arteries grafted into WT mice remained patent in vivo. In contrast, WT grafts underwent thrombosis and were completely occluded within 24 to 48 hours. The nonthrombogenic property of the TSP2 KO ECM was confirmed in vitro by exposing platelets to TSP2 KO dermal fibroblast (DF)-derived ECM. To further probe the effect of TSP2 deficiency, ECM production and deposition by WT and TSP2 KO DFs was analyzed via polymerase chain reaction, immunofluorescence, and scanning electron microscopy and showed similar patterns. In addition, atomic force microscopy (AFM) analysis of WT and TSP2 KO ECM did not reveal differences in stiffness. In contrast, reduced VWF accumulation on TSP2 KO ECM was observed when matrices were subjected to plasma under physiological flow. AFM utilizing VWF-coated 2-μm beads confirmed the weak binding to TSP2 KO ECM, providing a mechanistic explanation for the lack of thrombus formation. Therefore, our studies show that ECM assembly is critical for interaction of collagen with VWF and subsequent thrombogenic responses.

Indexed as

AnimalsBlood PlateletsCell AdhesionCollagenExtracellular MatrixFibroblastsHemostasisMiceMice, Inbred C57BLMice, KnockoutPlatelet AdhesivenessThrombosisThrombospondin 2Thrombospondinsvon Willebrand FactorCollagenThrombospondin 2Thrombospondinsvon Willebrand Factor

Identifiers

PMID27471233
PMCPMC5034742
OpenAlexW2504923827

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.